Differential response to anti-TNF therapy (Differential response of the rheumatoid factor and anti-citrullinated protein antibodies during adalimumab infliximab treatment in patients with rheumatoid arthritis suggests that RF and anti-CCP antibodies are independent autoantibody systems). The gene discussed is TNF; the disease is rheumatoid arthritis.